Title : Model based drug design (MBDD)

Therapeutic Area 1: Oncology

Primary objective of using MBDD in Oncology is to generate quantitative information to improve planning of oncology drug development. This information could pertain to risk factors for survival, disease model for change of tumor size over time and relationship between tumor size related metrics (early biomarker) and overall survival.